Wilshire Pharmaceuticals Inc.
42 drugs in NADAC|42 Generic,0 Brand
Wilshire Pharmaceuticals Inc. lists 42 NDCs in the CMS NADAC file (42 generic, 0 brand), at an average NADAC of $2.45 per unit, with a week-over-week move of +2.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
42
42G / 0B
Avg Price / Unit
$2.4460
$0.14 – $11.39
Avg 7d Change
+2.05%
Across 39 drugs with changes
7d Activity
of 42 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Dextroamphetamine Sulfate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Macrolide Antimicrobial therapeutic class
Review the broader class where Wilshire Pharmaceuticals Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Wilshire Pharmaceuticals Inc. make?
Wilshire Pharmaceuticals Inc. lists 42 NDCs in the CMS NADAC file — 42 generic and 0 brand products.
What is the average price of Wilshire Pharmaceuticals Inc. drugs?
The average NADAC across Wilshire Pharmaceuticals Inc.'s portfolio is $2.4460 per unit, ranging from $0.1354 to $11.3924.
What types of drugs does Wilshire Pharmaceuticals Inc. make?
Wilshire Pharmaceuticals Inc. makes drugs across 11 FDA pharmacologic classes. The most common by NDC count are Macrolide Antimicrobial (11), Macrolide (11), Central Nervous System Stimulant (9), Calcium Channel Blocker (7), Phenothiazine (4).
Has Wilshire Pharmaceuticals Inc. had any drug recalls?
No FDA enforcement recalls are matched to Wilshire Pharmaceuticals Inc. in the openFDA feed.
How has Wilshire Pharmaceuticals Inc.'s pricing changed recently?
Over the past 7 days, 16 Wilshire Pharmaceuticals Inc. products rose and 23 fell, with a portfolio-wide average change of +2.0%.